Primary Tumor Maximum Standardized Uptake Value Measured on 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Is a Prognostic Value for Survival in Bile Duct and Gallbladder Cancer.
10.4166/kjg.2013.62.4.227
- Author:
Ji Yong LEE
1
;
Hong Joo KIM
;
Seo Hyung YIM
;
Dong Suk SHIN
;
Jung Hee YU
;
Deok Yun JU
;
Jung Ho PARK
;
Dong Il PARK
;
Yong Kyun CHO
;
Chong Il SOHN
;
Woo Kyu JEON
;
Byung Ik KIM
Author Information
1. Department of Internal Medicine, Kangbuk Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. hongjoo3.kim@samsung.com
- Publication Type:Original Article
- Keywords:
Prognosis;
Fluorodeoxyglucose F18;
Positron-emission tomography and computed tomography;
Bile duct neoplasms;
Gallbladder neoplasms
- MeSH:
Aged;
Bile Duct Neoplasms/*diagnosis/mortality/radionuclide imaging;
Cholangiocarcinoma/diagnosis/mortality/radionuclide imaging;
Female;
Fluorodeoxyglucose F18/diagnostic use/metabolism/standards;
Gallbladder Neoplasms/*diagnosis/mortality/radionuclide imaging;
Humans;
Kaplan-Meier Estimate;
Liver Neoplasms/diagnosis/mortality/radionuclide imaging;
Male;
Middle Aged;
Neoplasm Staging;
Positron-Emission Tomography/standards;
Prognosis;
Proportional Hazards Models;
Radiopharmaceuticals/diagnostic use/metabolism/standards;
Retrospective Studies;
Tomography, X-Ray Computed/standards
- From:The Korean Journal of Gastroenterology
2013;62(4):227-233
- CountryRepublic of Korea
- Language:English
-
Abstract:
BACKGROUND/AIMS: Few studies have assessed the prognostic value of the primary tumor maximum standardized uptake value (SUVmax) measured by 2-[18F]-fluoro-2-deoxy-D-glucose PET-CT for patients with bile duct and gallbladder cancer. METHODS: A retrospective analysis of 61 patients with confirmed bile duct and gallbladder cancer who underwent FDG PET-CT in Kangbuk Samsung Medical Center (Seoul, Korea) from April 2008 to April 2011. Prognostic significance of SUVmax and other clinicopathological variables was assessed. RESULTS: Twenty-three patients were diagnosed as common bile duct cancer, 17 as hilar bile duct cancer, 12 as intrahepatic bile duct cancer, and nine as gallbladder cancer. In univariate analysis, diagnosis of intrahepatic cholangiocarcinoma and gallbladder cancer, mass forming type, poorly differentiated cell type, nonsurgical treatment, advanced American Joint Committee on Cancer (AJCC) staging and primary tumor SUVmax were significant predictors of poor overall survival. In multivariate analysis adjusted for age and sex, primary tumor SUVmax (hazard ratio [HR], 4.526; 95% CI, 1.813-11.299), advanced AJCC staging (HR, 4.843; 95% CI, 1.760-13.328), and nonsurgical treatment (HR, 6.029; 95% CI, 1.989-18.271) were independently associated with poor overall survival. CONCLUSIONS: Primary tumor SUVmax measured by FDG PET-CT is an independent and significant prognostic factor for overall survival in bile duct and gallbladder cancer.
